End Cash: The amount of cash held by the company for the given period.
Genmab A/S (GNMSF) had End Cash of $1.72B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.06B |
|
$31.00M |
|
$81.00M |
|
$977.00M |
|
$1.00B |
|
$58.00M |
|
$-3.00M |
|
$55.00M |
|
$55.00M |
|
$31.00M |
|
$31.00M |
|
$31.00M |
|
$31.00M |
|
$58.00M |
|
$79.00M |
|
62.15M |
|
62.69M |
|
$0.49 |
|
$0.44 |
|
| Balance Sheet Financials | |
$2.88B |
|
$153.00M |
|
$9.99B |
|
$12.87B |
|
$1.43B |
|
$5.00B |
|
$5.60B |
|
$7.03B |
|
$5.85B |
|
$-3.63B |
|
$5.85B |
|
64.24M |
|
| Cash Flow Statement Financials | |
$1.19B |
|
$-5.64B |
|
$4.79B |
|
$1.38B |
|
|
End Cash |
$1.72B |
$335.00M |
|
$128.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.02 |
|
-- |
|
-- |
|
0.46 |
|
0.90 |
|
92.34% |
|
5.48% |
|
5.48% |
|
-- |
|
5.20% |
|
2.93% |
|
$-6.07B |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
4.50 |
|
0.92 |
|
98.00 |
|
0.53% |
|
-0.85% |
|
0.24% |
|
0.29% |
|
$91.02 |
|
$-96.76 |
|
$18.92 |
|